B. Metzler Seel. Sohn & Co. Holding Ag Novavax Inc Transaction History

B. Metzler Seel. Sohn & Co. Holding Ag

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$10.71 - $17.11 $14,340 - $22,910	-1,339 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$177.8 - $270.58 $43,916 - $66,833	247 Added 22.62%	1,339 $278,000
Q2 2021 Aug 30, 2021	BUY	$121.0 - $257.67 $132,132 - $281,375	1,092 New	1,092 $232,000

286

84.7M

5.38M

8.62M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Holding Ag, based on Form 13F filings with the SEC.

Stay updated on B. Metzler Seel. Sohn & Co. Holding Ag with notifications on news.